# Immutep (IMMP) — News

IMMP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/immp/news

## Recent headlines

- [Immutep regains compliance with Nasdaq minimum bid price requirement](https://www.ainvest.com/news/immutep-regains-compliance-nasdaq-minimum-bid-price-requirement-2610) — AInvest Wire, Oct 13, 2026
- [Immutep Ltd - Resignation of non-executive director](https://www.ainvest.com/news/immutep-resignation-executive-director-2610) — AInvest Wire, Oct 4, 2026
- [Immutep - Announces change to ADS ratio quoted on Nasdaq](https://www.ainvest.com/news/immutep-announces-change-ads-ratio-quoted-nasdaq-2609) — AInvest Wire, Sep 21, 2026
- [Immutep - Targets next EFTI clinical trials start in 2H CY2027](https://www.ainvest.com/news/immutep-targets-efti-clinical-trials-start-2h-cy2027-2609) — AInvest Wire, Sep 11, 2026
- [Immutep - Contracts new manufacturing run of EFTI at 200 L scale](https://www.ainvest.com/news/immutep-contracts-manufacturing-run-efti-200-scale-2609) — AInvest Wire, Sep 11, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).